Isoplexis Quick Ratio (ISO) starting from the fourth quarter 2022 to fourth quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Isoplexis Corporation  (NASDAQ: ISO)

Isoplexis's Quick Ratio

ISO's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2022, Quick Ratio fell to 2.12 a new company low.

Within Laboratory Analytical Instruments industry 17 other companies have achieved higher Quick Ratio than Isoplexis in fourth quarter 2022. While Quick Ratio total ranking in the fourth quarter 2022 has deteriorated compared to the prior quarter from 778 to 1484.

Explain Quick Ratio?
How much Cash & cash equivalents ISO´s has?
What are ISO´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ISO Quick Ratio (Dec 31 2022)
Q4		 (Sep 30 2022)
Q3		 (Jun 30 2022)
Q2		 (Mar 31 2022)
Q1		 (Dec 31 2021)
Q4
Y / Y Current Liabilities Change 39.83 % 63.3 % 358.54 % - -
Y / Y Cash & cash equivalent Change -70.4 % 30.41 % -32.85 % - -
Quick Ratio MRQ 2.12 5.22 6.87 5.72 9.99
ISO's Total Ranking # 1484 # 778 # 597 # 738 # 401
Seq. Current Liabilities Change 73.94 % -2.27 % -38.96 % 34.75 % 103.14 %
Seq. Cash & cash equivalent Change -29.48 % -25.81 % -26.64 % -22.88 % 210.68 %



Quick Ratio fourth quarter 2022 Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 18
Healthcare Sector # 682
Overall Market # 1484


Quick Ratio Statistics
High Average Low
9.99 5.58 2.12
(Dec 31 2021)   (Dec 31 2022)




Financial Statements
Isoplexis's Current Liabilities $ 18 Millions Visit ISO's Balance sheet
Isoplexis's Cash & cash equivalent $ 37 Millions Visit ISO's Balance sheet
Source of ISO's Sales Visit ISO's Sales by Geography


Cumulative Isoplexis's Quick Ratio

ISO's Quick Ratio for the trailling 12 Months

ISO Quick Ratio

 (Dec 31 2022)
12 Months		 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months
Y / Y Current Liabilities TTM Growth 161.55 % 491.67 % 1941.64 % - -
Y / Y Cash & cash equivalent TTM Growth -5.16 % 136.74 % 215.56 % - -
Quick Ratio TTM 4.69 6.93 7.25 9.72 12.94
Total Ranking TTM # 4441 # 519 # 669 # 510 # 4212
Seq. Current Liabilities TTM Growth 10.02 % 8.51 % 21.3 % 80.61 % 148.89 %
Seq. Cash & cash equivalent TTM Growth -25.54 % 3.68 % -9.43 % 35.63 % 85.88 %

Quick ratio ranking by company, industry and sector >> Back to ISO Financial Strength Comparisons >> Go to Compare ISO Quick Ratio to its Competitors

On the trailing twelve months basis Due to jump in Current Liabilities in the Q4 2022 to $17.71 millions, cumulative Quick Ratio decreased to 4.69 below the Isoplexis Corporation average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Laboratory Analytical Instruments industry 30 other companies have achieved higher Quick Ratio than Isoplexis. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2022 from 519 to 4441.

Explain Quick Ratio?
How much Cash & cash equivalents ISO´s has?
What are ISO´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Laboratory Analytical Instruments Industry # 31
Healthcare Sector # 1155
Within the Market # 4441


trailing twelve months Quick Ratio Statistics
High Average Low
6.45 4.84 2.92
(Sep 30 2022)   (Dec 31 2021)




Companies with similar Quick Ratio in the quarter ending Dec 31 2022, within Laboratory Analytical Instruments Industry Quick RatioDec 31 2022 MRQ Cash & cash equivalentDec 31 2022 MRQ Current Liabilities
Scientific Industries Inc   4.20 $ 9.363  Millions$ 2.230  Millions
Pacific Biosciences Of California Inc   3.32 $ 772.318  Millions$ 232.390  Millions
Cue Health Inc   3.21 $ 241.530  Millions$ 75.261  Millions
Bionano Genomics Inc   2.62 $ 113.186  Millions$ 43.165  Millions
Waters Corporation  2.61 $ 481.862  Millions$ 184.270  Millions
Akoya Biosciences Inc   2.57 $ 81.218  Millions$ 31.642  Millions
Prenetics Global Limited  2.56 $ 146.660  Millions$ 57.195  Millions
Lifeloc Technologies Inc   2.51 $ 2.353  Millions$ 0.936  Millions
Telesis Bio Inc   2.25 $ 30.419  Millions$ 13.498  Millions
Isoplexis Corporation  2.12 $ 37.465  Millions$ 17.711  Millions
Olink Holding Ab publ   2.08 $ 75.109  Millions$ 36.087  Millions
Phenomex Inc   1.90 $ 86.522  Millions$ 45.490  Millions
Bio rad Laboratories Inc   1.70 $ 762.375  Millions$ 449.519  Millions
Htg Molecular Diagnostics Inc  1.48 $ 12.211  Millions$ 8.271  Millions
Precipio inc   0.89 $ 3.445  Millions$ 3.881  Millions
Accelerate Diagnostics Inc   0.87 $ 55.318  Millions$ 63.628  Millions
Bruker Corporation  0.86 $ 664.500  Millions$ 775.900  Millions
Agilent Technologies inc   0.73 $ 1,053.000  Millions$ 1,434.000  Millions

Date modified: 2026-09-08T15:10:51+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.